Search Results - "ARTAL, Angel"

Liposomal Doxorubicin in the Treatment of Breast Cancer Patients: A Review by Lao, Juan, Madani, Julia, Puértolas, Teresa, Álvarez, María, Hernández, Alba, Pazo-Cid, Roberto, Artal, Ángel, Antón Torres, Antonio

“…Drug delivery systems can provide enhanced efficacy and/or reduced toxicity for anticancer agents. Liposome drug delivery systems are able to modify the…”
Get full text

Ribonucleotide Reductase Messenger RNA Expression and Survival in Gemcitabine/Cisplatin-Treated Advanced Non-Small Cell Lung Cancer Patients by ROSELL, Rafael, DANENBERG, Kathleen D, ARTAL, Angel, ALBEROLA, Vincente, BEPLER, Gerold, SANCHEZ, Jose Javier, CAMPS, Carlos, PROVENCIO, Mariano, ISLA, Dolores, TARON, Miquel, DIZ, Pilar

“…Purpose: No chemotherapy regimen, including the widely used combination of gemcitabine/cisplatin, confers significantly improved survival over any other in…”
Get full text

Clinical management and outcome of patients with advanced NSCLC carrying EGFR mutations in Spain by Arriola, Edurne, García Gómez, Ramón, Diz, Pilar, Majem, Margarita, Martínez Aguillo, Maite, Valdivia, Javier, Paredes, Alfredo, Sánchez-Torres, José Miguel, Peralta Muñoz, Sergio, Barneto, Isidoro, Gutierrez, Vanesa, Andrade Santiago, Jesús Manuel, Aparisi, Francisco, Isla, Dolores, Ponce, Santiago, Vicente Baz, David, Artal, Angel, Amador, Mariluz, Provencio, Mariano

“…Although the benefit of first-line epidermal growth factor receptor (EGFR) tyrosine-kinase inhibitors (TKIs) over chemotherapy has been demonstrated in several…”
Get full text

Long-Term Survival Associated With Complete Resection After Induction Chemotherapy in Stage IIIA (N2) and IIIB (T4N0-1) Non–Small-Cell Lung Cancer Patients: The Spanish Lung Cancer Group Trial 9901 by Garrido, Pilar, González-Larriba, José Luis, Insa, Amelia, Provencio, Mariano, Torres, Antonio, Isla, Dolores, Sanchez, José Miguel, Cardenal, Felipe, Domine, Manuel, Barcelo, Jose Ramon, Tarrazona, Vicente, Varela, Andres, Aguilo, Rafael, Astudillo, Julio, Muguruza, Ignacio, Artal, Angel, Hernando-Trancho, Florentino, Massuti, Bartomeu, Sanchez-Ronco, Maria, Rosell, Rafael

“…To assess the activity of induction chemotherapy followed by surgery in stage IIIA and selected stage IIIB non-small-cell lung cancer patients. Mediastinoscopy…”
Get full text

Reflections on the Implementation of Low-dose Computed Tomography Screening in Individuals at High Risk of Lung Cancer in Spain by Garrido, Pilar, Sánchez, Marcelo, Belda Sanchis, José, Moreno Mata, Nicolás, Artal, Ángel, Gayete, Ángel, Matilla González, José María, Galbis Caravajal, José Marcelo, Isla, Dolores, Paz-Ares, Luis, Seijo, Luis M.

“…Lung cancer (LC) is a major public health issue. Despite recent advances in treatment, primary prevention and early diagnosis are key to reducing the incidence…”
Get full text

Management of the adverse events of afatinib: a consensus of the recommendations of the Spanish expert panel by Arriola, Edurne, Reguart, Noemi, Artal, Angel, Cobo, Manuel, García-Campelo, Rosario, Esteban, Emilio, Rodríguez, Mari Carmen, García-Muret, Maria Pilar

“…Afatinib is an irreversible ErbB family blocker tyrosine kinase inhibitor (TKI), which has recently been approved for the treatment of patients with EGFR M+…”
Get full text

Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial by Fehrenbacher, Louis, Dr, Spira, Alexander, MD, Ballinger, Marcus, PhD, Kowanetz, Marcin, PhD, Vansteenkiste, Johan, Prof, Mazieres, Julien, Prof, Park, Keunchil, Prof, Smith, David, MD, Artal-Cortes, Angel, MD, Lewanski, Conrad, MD, Braiteh, Fadi, MD, Waterkamp, Daniel, MD, He, Pei, PhD, Zou, Wei, PhD, Chen, Daniel S, MD, Yi, Jing, PhD, Sandler, Alan, MD, Rittmeyer, Achim, MD

“…Summary Background Outcomes are poor for patients with previously treated, advanced or metastatic non-small-cell lung cancer (NSCLC). The anti-programmed death…”
Get full text

Randomized Phase III Study of Gemcitabine-Cisplatin Versus Etoposide-Cisplatin in the Treatment of Locally Advanced or Metastatic Non–Small-Cell Lung Cancer by Cardenal, F, López-Cabrerizo, M P, Antón, A, Alberola, V, Massuti, B, Carrato, A, Barneto, I, Lomas, M, García, M, Lianes, P, Montalar, J, Vadell, C, González-Larriba, J L, Nguyen, B, Artal, A, Rosell, R

“…We conducted a randomized trial to compare gemcitabine-cisplatin with etoposide-cisplatin in the treatment of patients with advanced non-small-cell lung cancer…”
Get full text

Long-term COVID-19 pandemic impact on suicide Thoughts and Behaviors (STB): An interrupted time series analysis in Spain 2-year after pandemic outbreak by Gómez-Revuelta, Marcos, Sánchez-Lafuente, Carlos Gómez, Yáñez, Javier Sastre, Pindado, Luis Mariano Gaite, Echevarría, Luisa Elvira San Emeterio, Meseguer, Telva Carceller, Ruiz, Elsa Gómez, Bourgon, Javier Vázquez, Simón, Jesús Ángel Artal, Díaz, Ana Isabel de Santiago, Terán, José María Pelayo

“…•The early STB decrease during COVID-19 lockdown reversed, especially affecting young and older populations later.•Economic stress and social isolation during…”
Get full text

Opening Windows for Thymic Tumors by Artal-Cortes, Angel F, Verdún-Aguilar, Juan, Márquez-Medina, Diego

Get more information

Recurrence of suicidal thoughts and behaviors during one year of follow-up: An exploratory study by Suárez-Pinilla, Paula, Pérez-Herrera, Marina, Suárez-Pinilla, Marta, Medina-Blanco, Raquel, López-García, Enrique, Artal-Simón, Jesús Ángel, de Santiago-Díaz, Ana Isabel

“…•31.5% patients with suicidal thoughts or behaviors recurred in 1-year follow-up.•Around 70% % of recurrences occurred in the first 6 months.•Seeking…”
Get full text

Bilateral Choroidal Metastases Revealing an Advanced Non-Small Cell Lung Cancer by Ascaso, Francisco J., MD, Castillo, Jesús M., MD, García, Francisco J., MD, Cristóbal, José A., MD, Fuertes, Ana, MD, Artal, Angel, MD

“…Choroidal metastases are metastatic lesions to the choroid layer of the eye. Although infrequent, they may be the initial manifestation of lung cancer. To…”
Get full text

Lung immune prognostic index (LIPI) as a prognostic factor in patients with extensive-stage small cell lung cancer treated with first-line chemoimmunotherapy by Herranz-Bayo, Elena, Chara-Velarde, Luis Enrique, Cassinello-Espinosa, Javier, Gimeno-Ballester, Vicente, Artal-Cortés, Ángel, Moratiel-Pellitero, Alba, Alcácera-López, Arancha, Navarro-Expósito, Fátima, Riesco-Montes, Blanca, Clemente-Andujar, Manuel

“…The lung immune prognostic index (LIPI) is a biomarker that combines the lactate dehydrogenase (LDH) value and the derived neutrophil/lymphocyte ratio (dNLR)…”
Get full text

Management of lung cancer-associated anaemia: the Spanish Lung Cancer Anaemia Survey (SLCAS) by Gascón, Pere, Almenárez, José, Artal, Ángel, Camps, Carlos, Fírvida, José Luis, Garrido, Pilar, González Larriba, José Luis, Montalar, Joaquín

“…Background The purpose of the Spanish Lung Cancer Anaemia Survey (SLCAS) was to thoroughly investigate lung cancer-associated anaemia management, and describe…”
Get full text

Massive Hemoptysis after the First Administration of Pembrolizumab in a Strongly Positive, Centrally Located NSCLC by Artal-Cortés, Angel, Felices-Lobera, Pilar, Márquez-Medina, Diego

Get more information

Brief report: High incidence of peridiagnosis thromboembolic events in patients with BRAF-mutant lung cancer by Aparicio, Inmaculada, Iranzo, Patricia, Reyes, Roxana, Bote, Helena, Saigi, María, Bringas, Marianela, Bosch-Barrera, Joaquim, Corral, Jesús, Aparisi, Francisco, Ruffinelli, Jose C., Jiménez, Beatriz, Lage, Yolanda, López-Castro, Rafael, Majem, Margarita, Vázquez, Sergio, Artal, Ángel, Rodríguez-Pérez, Ángel, Lázaro-Quintela, Martín, Torres, José Miguel Sánchez, Reguart, Noemí, Cucurull, Marc, Gil-Bazo, Ignacio, Camps, Carlos, Nadal, Ernest, del Barrio, Anabel, Garrido, Pilar, Dómine, Manuel, Álvarez, Rosa, Muñoz, Andrés J., Calles, Antonio

“…INTRODUCTIONWe aimed to determine if advanced BRAF-mutant NSCLC has a higher thromboembolic events (TEE) rate than the expected.METHODSBetween 2008 and 2021,…”
Get full text

External Beam Radiation Therapy for Palliation of Symptomatic Bone Metastases: An ASTRO Clinical Practice Guideline by Alcorn, Sara, Cortés, Ángel Artal, Bradfield, Lisa, Brennan, Margaret, Dennis, Kristopher, Diaz, Dayssy A., Doung, Yee-Cheen, Elmore, Shekinah, Hertan, Lauren, Johnstone, Candice, Jones, Joshua, Larrier, Nicole, Lo, Simon S., Nguyen, Quynh-Nhu, Tseng, Yolanda D., Yerramilli, Divya, Zaky, Sandra, Balboni, Tracy

“…This guideline provides evidence-based recommendations for palliative external beam radiation therapy (RT) in symptomatic bone metastases. The ASTRO convened a…”
Get full text

LungBEAM: A prospective multicenter study to monitor stage IV NSCLC patients with EGFR mutations using BEAMing technology by Garrido, Pilar, Paz‐Ares, Luis, Majem, Margarita, Morán, Teresa, Trigo, José Manuel, Bosch‐Barrera, Joaquim, Garcίa‐Campelo, Rosario, González‐Larriba, José Luis, Sánchez‐Torres, José Miguel, Isla, Dolores, Viñolas, Núria, Camps, Carlos, Insa, Amelia, Juan, Óscar, Massuti, Bartomeu, Paredes, Alfredo, Artal, Ángel, López‐Brea, Marta, Palacios, José, Felip, Enriqueta

“…Objectives The aim of LungBEAM was to determine the value of a novel epidermal growth factor receptor (EGFR) mutation test in blood based on BEAMing technology…”
Get full text

Prospective Exploratory Analysis of Angiogenic Biomarkers in Peripheral Blood in Advanced NSCLC Patients Treated With Bevacizumab Plus Chemotherapy: The ANGIOMET Study by Jantus-Lewintre, Eloisa, Massutí Sureda, Bartomeu, González Larriba, José Luis, Rodríguez-Abreu, Delvys, Juan, Oscar, Blasco, Ana, Dómine, Manuel, Provencio Pulla, Mariano, Garde, Javier, Álvarez, Rosa, Maestu, Inmaculada, Pérez de Carrión, Ramón, Artal, Ángel, Rolfo, Christian, de Castro, Javier, Guillot, Mónica, Oramas, Juana, de las Peñas, Ramón, Ferrera, Lioba, Martínez, Natividad, Serra, Òlbia, Rosell, Rafael, Camps, Carlos

“…Finding angiogenic prognostic markers in advanced non-small-cell lung cancer is still an unmet medical need. We explored a set of genetic variants in the…”
Get full text

Patterns of Progression and Feasibility of Re-biopsy After First-line Erlotinib for Advanced EGFR Mutation-positive Non-small-cell Lung Cancer by Ortega-Granados, Ana Laura, Artal-Cortes, Ángel, Aguiar-Bujanda, David, Oramas, Juana, Fírvida, José Luis, DE Castro, Javier, Fuentes, Juana Campillo, Gordo, Rocío, Galán, Raquel, Trigo, José

“…To assess the patterns of disease progression in advanced/metastatic epidermal growth factor receptor (EGFR)-mutant non-small-cell lung cancer (NSCLC) on…”
Get full text